These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis. Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673 [TBL] [Abstract][Full Text] [Related]
5. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients. Furlan A; Close ON; Borhani AA; Wu YH; Heller MT Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891 [TBL] [Abstract][Full Text] [Related]
7. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents. Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212 [TBL] [Abstract][Full Text] [Related]
8. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310 [TBL] [Abstract][Full Text] [Related]
9. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. Allen BC; Ho LM; Jaffe TA; Miller CM; Mazurowski MA; Bashir MR AJR Am J Roentgenol; 2018 Jun; 210(6):1266-1272. PubMed ID: 29629800 [TBL] [Abstract][Full Text] [Related]
11. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution. Well L; Rausch VH; Adam G; Henes FO; Bannas P Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909 [No Abstract] [Full Text] [Related]
12. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice. Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655 [TBL] [Abstract][Full Text] [Related]
13. An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Motosugi U; Bannas P; Bookwalter CA; Sano K; Reeder SB Radiology; 2016 Apr; 279(1):93-102. PubMed ID: 26473642 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study. Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108 [TBL] [Abstract][Full Text] [Related]
15. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material. Gilligan LA; Trout AT; Anton CG; Schapiro AH; Towbin AJ; Dillman JR Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405 [TBL] [Abstract][Full Text] [Related]
16. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging. Hayashi T; Saitoh S; Tsuji Y; Takahashi J; Tagaya N; Hiramoto M; Fukuzawa K; Tano M; Miyati T; Kumada H Radiology; 2015 Sep; 276(3):756-65. PubMed ID: 25811243 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119 [TBL] [Abstract][Full Text] [Related]
18. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544 [TBL] [Abstract][Full Text] [Related]